Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 44:1510-1520, doi:10.1016/j.jacc.2004.05.083
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maekawa, Y.
Right arrow Articles by Ogawa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maekawa, Y.
Right arrow Articles by Ogawa, S.

Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction

Yuichiro Maekawa, MD, Toshihisa Anzai, MD*, Tsutomu Yoshikawa, MD, Yasuo Sugano, MD, Keitaro Mahara, MD, Takashi Kohno, MD, Toshiyuki Takahashi, MD and Satoshi Ogawa, MD, FACC

Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan



View larger version (29K):

[in a new window]
 
Figure 1 (A) Representative hematoxylin-eosin-stained midventricular cross-sections of myocardial infarction rats treated with saline (MI/C) and myocardial infarction treated with romurtide (MI/Ro) on day 14. (B) Expansion index on day 14 in MI/C and MI/Ro (n = 4 per group). Values are mean ± SEM. *p < 0.05 versus MI/C.

 


View larger version (20K):

[in a new window]
 
Figure 2 (A) Time course difference of peripheral leukocyte count among sham-operated rats (Sham), Sham treated with romurtide (Sham/Ro), myocardial infarction rats treated with saline (MI/C), and myocardial infarction treated with romurtide (MI/Ro) (n = 4 per group). (B) Time course difference of peripheral monocyte count among Sham, Sham/Ro, MI/C, and MI/Ro (n = 4 per group). Values are mean ± SEM. *p < 0.05 versus Sham; {dagger}p < 0.05 versus MI/C.

 


View larger version (45K):

[in a new window]
 
Figure 3 (A) Representative immunoblots showing transforming growth factor (TGF)-ß1 protein level in the infarcted and non-infarcted sites on days 3 and 14 among sham-operated rats (Sham), Sham treated with romurtide (Sham/Ro), myocardial infarction rats treated with saline (MI/C), and MI treated with romurtide (MI/Ro). (B) Quantified data of TGF-ß1 protein expression in the infarcted and non-infarcted sites among Sham, Sham/Ro, MI/C, and MI/Ro (n = 4 per group). Values are mean ± SEM. *p < 0.05 versus Sham; {dagger}p < 0.05 versus Sham/Ro; {ddagger}p < 0.05 versus MI/C.

 



View larger version (51K):

[in a new window]
 
Figure 4 Effects of romurtide administration on monocyte chemoattractant protein (MCP)-1, transforming growth factor (TGF)-ß1, and collagen type I and collagen type III messenger ribonucleic acid (mRNA) expression in the infarcted and non-infarcted sites. Quantitative analyses showing (A) MCP-1, (B) TGF-ß1, (C) collagen type I, and (D) collagen type III mRNA expression in the infarcted sites and (E) MCP-1, (F) TGF-ß1, (G) collagen type I, and (H) collagen type III mRNA expression in the non-infarcted sites with real-time reverse transcription polymerase chain reaction analyses among sham-operated rats (Sham), Sham treated with romurtide (Sham/Ro), myocardial infarction rats treated with saline (MI/C), and MI treated with romurtide (MI/Ro) (n = 5 per group). Values are mean ± SEM. *p < 0.05 versus Sham; {dagger}p < 0.05 versus Sham/Ro; {ddagger}p < 0.05 versus MI/C. Continued on next page.

 


View larger version (71K):

[in a new window]
 
Figure 5 (A) Results of immunohistochemical staining of the infarcted sites of the myocardial infarction rats treated with saline (MI/C) and MI treated with romurtide (MI/Ro), and of the left ventricle (LV) of the sham-operated rats (Sham) and Sham treated with romurtide (Sham/Ro) on day 7 with use of monoclonal anti-ED-1 and anti-monocyte chemoattractant protein-1 (anti-MCP-1)antibodies (magnification 400x). The ED-1-positive macrophages and MCP-1-positive cells are stained brown. (B) Mallory-Azan staining in the infarcted sites of the MI animals (MI/C and MI/Ro) and in the LV of the sham animals (Sham and Sham/Ro) on days 7 and 14 (magnification 400x). Fibrous tissue appears blue. (C) Collagen content in the infarcted and non-infarcted sites of MI/C and MI/Ro and in the LV of Sham and Sham/Ro (n = 4 per group). Values are mean ± SEM. *p < 0.05 versus Sham; {dagger}p < 0.05 versus Sham/Ro; {ddagger}p < 0.05 versus MI/C.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement